z-logo
Premium
Toll‐like receptor 4 mutation delays the onset of insulin resistance in post‐menopausal mice fed a high fat diet
Author(s) -
Brooks Heddwen L,
Hoyer Patricia B,
Tsao TsuShuen,
RomeroAleshire Melissa J
Publication year - 2011
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.25.1_supplement.835.11
Subject(s) - insulin resistance , endocrinology , medicine , toll like receptor , mutation , receptor , insulin receptor , insulin , biology , genetics , gene , innate immune system
Previous studies in the VCD‐model of menopause demonstrated that the development and progression of metabolic syndrome was accelerated when mice were fed a high‐fat diet. Fatty acids are able to activate toll‐like receptor 4 (TLR4) signaling and in turn, TLR4 can mediate inflammatory events and insulin resistance in peripheral organs. In this study mice heterozygous for a TLR4 mutation were fed a high‐fat (HF) diet and dosed with VCD, to induce menopause (VCD/HF). Previously, VCD‐treated mice became hyperinsulinemic and insulin resistant after 12 weeks on a high fat diet. In contrast, VCD‐treated mice with a TLR4 mutation took 20 weeks on a high fat diet to become hyperinsulinemic (VCD/HF 2.6±0.29 vs HF 1.8±0.41 and Con 0.6±0.15 ng/ml) and to develop insulin resistance (VCD/HF 25.6±3.1 vs HF 15.5±1.5 and Con 5.3±1.9 mg/dl*uU/ml). Circulating levels of leptin and adiponectin were examined: adiponectin levels were reduced in both VCD/HF and HF mice after 12 weeks on a high fat diet, in contrast leptin levels were significantly higher in VCD‐treated mice after 16 weeks on a high fat diet compared to all other groups (VCD/HF 33.9±10 vs HF 12.8±1.2 and Con 2.9±1.3 ng/ml). This study suggests that loss of TLR4 infers a resistance to the onset of insulin resistance; however hormonal changes that occurred during menopause continued to promote the development of insulin resistance.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here